Drugs / T1675
last change May 2005 re-read 3 minutes ago

T1675

Developed for
dry eye syndrome
Investigated by
Laboratoires Thea

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00357201 Nov 2004 → May 2005 dry eye syndrome Laboratoires Thea Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as T1675 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00357201 ↗
Route Oral “per os” NCT00357201 ↗